Effect of Peripheral Defocus on Axial Growth in Hyperopes
The Effect of Peripheral Defocus on Axial Growth and Modulation of Refractive Error in Hyperopes
1 other identifier
interventional
39
1 country
2
Brief Summary
Hyperopia, also known as farsightedness, is a common type of refractive error where distant objects may be seen more clearly than objects that are near. Hyperopia is a known risk factor for amblyopia, (lazy eye), which may occur as a result of a squint (turn), or due to different levels of hyperopia between each eye (anisohyperopia). Hyperopia and anisohyperopia often persist into adulthood resulting in impairment to binocular vision. Current management involves prescribing spectacles or contact lenses to correct the hyperopia in each eye, usually as a lifelong intervention. In recent years there has been a great deal of interest in delaying progression of myopia (short-sightedness) by slowing down the growth of the eye using a particular type of contact lens termed a centre-distance multifocal design. There have been some encouraging results in this area to date. The proposed study here would explore the use of centre-near multifocal design contact lenses to encourage growth of the eye, thereby reducing hyperopia. There are three elements to the programme of research:
- 1.The natural progression of axial growth and refractive error will be measured in hyperopic and anisohyperopic subjects aged between 5 and 19. In other words, the natural growth of the eye will be followed without any intervention
- 2.As a paired eye control study anisohyperopes aged between 8 and 15 will be fitted with a centre-near multifocal design contact lens in their more hyperopic eye and a single vision contact lens in the fellow eye, if required. The progression of axial growth and refractive error will be measured and compared in each eye
- 3.Subjects' aged between 8 and 15 with similar levels of hyperopia in each eye will be fitted with centre-near multifocal design contact lenses in each eye. The progression of axial growth and refractive error will be measured and compared to subjects in the natural progression study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2016
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2016
CompletedFirst Posted
Study publicly available on registry
February 22, 2016
CompletedStudy Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedMarch 3, 2022
February 1, 2022
3.8 years
February 12, 2016
February 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement in axial length change in mm
Axial length measured at baseline. Intervention introduced six months after baseline measures for a period of two years. Final measures taken six months after removal of intervention. Total time frame of three years.
Three years
Secondary Outcomes (1)
Measurement of refractive change in dioptres
Three years
Study Arms (4)
Natural progession
NO INTERVENTIONFollowing the natural progression of axial growth and refractive error.
Anisohyperopes - intervention eye
EXPERIMENTALThe more hyperopic eye will be fitted with a centre-near multifocal contact lens
Hyperopes
EXPERIMENTALBoth eyes will be fitted with centre-near multifocal contact lenses.
Anisohyperopes - fellow eye
EXPERIMENTALThe less hyperopic eye will be fitted with a single vision contact lens if required.
Interventions
Eligibility Criteria
You may qualify if:
- Aged between 5 and 19 years at the initial examination for the natural progression arm
- Aged between 8 and 15 years at the initial examination for the intervention arms
- Parents must have read, understood and signed informed consent form
- Participants must have read, understood and signed assent form
- Participants in the intervention groups agree to wear the prescribed contact lenses for a minimum of 10 hours per day, at least 6 days per week for the 2-year duration of the intervention period
- Be in good general health with no contraindications to contact lens wear
- Maximum manifest spherical refractive error of +6.00D
- Maximum manifest cylindrical refractive error of -1.00D
- Minimum anisometropia of 1.25D in the anisohyperopic group (mean spherical error)
- Maximum anisometropia of 1.00D in the non-anisohyperopic group (mean spherical error)
- Minimum mean spherical refractive error of +2.00D in the more hyperopic eye
- Be competent at handling contact lenses and understand the instructions given to ensure safe wear.
You may not qualify if:
- Participating within another clinical study (even if it is only an observational study?)
- Regular use of medication to treat ocular conditions
- Current use of systemic medication that may impact upon successful contact lens wear or affect focusing ability
- Known ocular or systemic disease
- Findings identified during contact lens assessment that would preclude contact lens wear.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aston Universitylead
- College of Optometristscollaborator
Study Sites (2)
Eyesite Eyecare Centres
Coventry, Walsgrave, CV2 4BA, United Kingdom
Aston University
Birmingham, West Midlands, B4 7ET, United Kingdom
Related Publications (1)
Beasley IG, Davies LN, Logan NS. Effect of Peripheral Defocus on Axial Eye Growth and Modulation of Refractive Error in Hyperopes: Protocol for a Nonrandomized Clinical Trial. JMIR Res Protoc. 2018 Sep 5;7(9):e173. doi: 10.2196/resprot.9320.
PMID: 30185407DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2016
First Posted
February 22, 2016
Study Start
June 1, 2016
Primary Completion
March 1, 2020
Study Completion
February 1, 2022
Last Updated
March 3, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share